Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Vismodegib Patent Expiration

Vismodegib is Used for treating basal cell carcinoma and cancer in mammals. It was first introduced by Genentech Inc in its drug Erivedge on Jan 30, 2012.


Vismodegib Patents

Given below is the list of patents protecting Vismodegib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Erivedge US7888364 Pyridyl inhibitors of hedgehog signalling Nov 11, 2028 Genentech
Erivedge US9278961 Pyridyl inhibitors of hedgehog signalling Dec 15, 2028 Genentech
Erivedge US9790183 Pyridyl inhibitors of hedgehog signalling Sep 02, 2025 Genentech


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳